MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.

Data de publicació:

Autors de IIS La Fe

Grups d'Investigació

Abstract

Neuroblastoma is an embryonal tumor of neuroectodermal cells. Patients with metastatic neuroblastoma have a poor survival rate, which has led to numerous efforts to develop prognostic markers. Cancer/testis-specific antigens MAGE-A1 and MAGE-A3 genes were proposed as minimal residual disease (MRD) markers in neuroblastoma, but its usefulness for this purpose is rather limited.

Dades de la publicació

ISSN/ISSNe:
0171-5216, 1432-1335

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY  SPRINGER

Tipus:
Article
Pàgines:
523-531
PubMed:
18820946
Factor d'Impacte:
1,044 SCImago
Quartil:
Q1 SCImago

Cites Rebudes en Web of Science: 16

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Projectes associats

ESTUDIO DE FASE I/II DE CP-751,871 EN PACIENTES CON TUMORES DE LA FAMILIA DE SARCOMAS DE EWING RECURRENTES Y/O REFRACTARIOS.

Investigador Principal: VICTORIA CASTEL SÁNCHEZ

A4021020 . 2008

Compartir la publicació